Search Results - "Piedra, Patricia"

  • Showing 1 - 12 results of 12
Refine Results
  1. 1

    Nimotuzumab, a promising therapeutic monoclonal for treatment of tumors of epithelial origin by Ramakrishnan, Melarkode S., Eswaraiah, Anand, Crombet, Tania, Piedra, Patricia, Saurez, Giselle, Iyer, Harish, Arvind, A.S.

    Published in mAbs (01-01-2009)
    “…Nimotuzumab is a humanized therapeutic monoclonal antibody against epidermal growth factor receptor (EGFR).  Clinical trials are ongoing globally to evaluate…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Efectividad y seguridad del uso de ior® EPOCIM en pacientes en prediálisis Ensayo clínico by Alicia Vargas Batista, Jorge Pérez-Oliva Díaz, Maytée Robaina García, Patricia Piedra Sierra, Ivis Mendoza Hernández, Yusnely Román Rodríguez

    Published in Revista habanera de ciencias médicas (01-12-2016)
    “…Introducción: El ior® EPOCIM (eritropoyetina humana recombinante), es un medicamento cubano que se produce en el Centro de Inmunología Molecular, el cual ha…”
    Get full text
    Journal Article
  4. 4

    Clinical experience with nimotuzumab in cuban pediatric patients with brain tumors, 2005 to 2007 by Saurez, Giselle, Cabanas, Ricardo, Zaldívar, Melba, Garnier, Tania, Iglesias, Bárbara, Piedra, Patricia, Castillo, Martha Ríos, Longchong, Martha, Iznaga, Normando, Lage, Agustín

    Published in MEDICC review (01-07-2009)
    “…Introduction Nimotuzumab, developed in Cuba, is a humanized monoclonal antibody that targets the epidermal growth factor receptor (EGFR). It has been evaluated…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Efficacy and safety of iorEPOCIM for chemotherapy- or radiotherapy-induced anemia in pediatric cancer patients by Vargas, Alicia, Mendoza, Ivis, Uranga, Rolando, González, Alejandro, Martínez, Liliana, Caballero, Iraida, Piedra, Patricia, Saurez, Giselle, Verdecia, Manuel, Cabanas, Ricardo

    Published in MEDICC review (01-07-2010)
    “…Recombinant human erythropoietin (RHuEPO) is an erythropoiesis stimulating agent (ESA) used to treat anemia in patients with total or relative erythropoietin…”
    Get full text
    Journal Article
  7. 7

    Towards the definition of a chimpanzee and human conserved CD6 domain 1 epitope recognized by T1 monoclonal antibody by Alonso, Ruby, Huerta, Vivian, de Leon, Joel, Piedra, Patricia, Puchades, Yaquelin, Guirola, Osmany, Chinea, Glay, Montero, Enrique

    Published in Hybridoma (2005) (01-08-2008)
    “…Scavenger receptor cysteine-rich (SRCR) domains are evolutionally conserved modules that display complex structures stabilized by key amino acids, while some…”
    Get more information
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12